Reading time is 4 mins
WHAT IS ATOPIC DERMATITIS? WHO HAS ATOPIC DERMATITIS?
Experts from the Turkish Society of Dermatoimmunology and Allergy and the Society of Allergy and Life gave important information about the disease. Referring to the importance of raising awareness about Atopic Dermatitis in society, the experts listed what the patient and his relatives should know.
Atopic Dermatitis, which can seen in a very wide age range from infancy to adulthood, manifested by skin dryness and severe itching, is actually a fairly common chronic skin disease. It can affect the quality of life quite negatively due to itching that lasts for days and a disorder in sleep patterns.
Due to Atopic Dermatitis Day, the Association of Dermatoimmunology and Allergy and the Association of Allergy and Life held a press conference with the unconditional support of Sanofi Genzyme to raise awareness about this issue in our country and gave information about the disease.
Can be controlled
Chairman of the Association of Dermatoimmunology and Allergy Prof. Dr. pointed out that not every eczema is the same thing as Atopic Dermatitis and gave the following information:
“Atopic Dermatitis is a chronic, long-term, recurrent, very itchy skin disease that is common at any age, but especially in childhood. Atopic Dermatitis, the incidence of which is increasing every day in developed societies, is a common eczema accompanied by severe itching, accompanied by itching marks and a pronounced dryness of the skin, and I would especially like to note that it is a non-infectious disease.
The affected areas, on the other hand, differ according to age. In infants, it is more common on the face, cheeks, behind the ears, neck, face in children, as well as on the arms and legs, wrists, outer parts of the hands and feet. In adults, it is more common on the face, nape, neck, back, and hands and feet. Infections can also easily develop in these examatized areas accompanied by severe itching.”
Vice-President of the Association of Turkish Dermatoimmunology and Allergy Prof. Dr. also mentioned in his speech that Atopic Dermatitis is a disease that significantly affects the social life of a person, both his own and his family, and said:
“This disease is a chronic, recurrent disease that can occur with very severe attacks from time to time. Severe itching in patients causes serious sleep and concentration problems, negatively affects both a person’s social life and his work and school performance. For this reason, these patients should be diagnosed as soon as possible and appropriate treatment should be started. Thus, the disease is significantly controlled and patients are provided with a normal life”.
Beware of unscientific solutions!
Speaking at the meeting, the President of the Association also stated that the biggest problem was the patient’s access to the diagnosis and gave the following information:
“In fact, when we see the first symptoms, deformation in the form of wounds on the skin may not occur at all if we contact a specialist and start treatment. We expect that the treatment will give immediate, very sudden results, and we lose confidence in the health system when the treatment period lasts longer than expected. However, the fact that we accept that treatment may take a long time in chronic diseases such as Atopic Dermatitis and that we do not disrupt the controls significantly affects the success of treatment.”
Emphasizing that products and treatments that are found on the Internet and are advertised as a 100 percent solution and are not scientific should not be respected, Allergy Prof. Dr. concluded his words as follows:
“Due to the fact that our health literacy as a society is not enough, patients sometimes turn to scientifically unproven methods in search of hope. This situation can cause material and moral damage to patients. That’s why it’s so important that families are aware of this as well. With the correct diagnosis and proper treatment in a timely manner, it is possible to improve the quality of life of these patients.”
What you need to know about atopic dermatitis
The incidence of atopic Dermatitis in children is on average 20-25 percent. 20-30 percent of the disease seen in childhood continues into adulthood. The disease is observed from the age of 5-6 months of infancy and 85 percent before the age of 5 years.
Between 2 and 10 percent of adults worldwide are affected by Atopic Dermatitis, and 10 percent of adult patients have severe this disease.
Itching in more than 60 percent of patients with moderate to severe Atopic Dermatitis lasts more than 12 hours a day.
45 percent of atopic dermatitis patients say that their itching affects their work life “often” or “all the time”.
65 percent of adult patients with Atopic Dermatitis have trouble sleeping. 55 percent of patients experience sleep splitting more than 5 nights a week. Children with severe Atopic Dermatitis experience sleep loss at least 168 days a year.
50 percent of adults with Atopic Dermatitis avoid social interactions because of their appearance, and 50 percent experience depression and/or anxiety.
1 out of every 4 children under the age of 13 with Atopic Dermatitis and 4 out of every 10 children between the ages of 13 and 16 are exposed to negative physical or psychological effects from their environment due to their disease.
75 percent of patients with moderate and severe Atopic Dermatitis have concomitant allergic diseases such as asthma, allergic rhinitis.